Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bicalutamide vs Placebo in Non-metastatic Prostate Cancer
NCT00673205Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Sep 1995
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 3 trial of bicalutamide in prostate cancer (PCa), sponsored by AstraZeneca. Started Sep 1995; status: completed.
02
Drugs
bicalutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00673205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00673205.